Biologics have only ‘slight impact’ vs. conventional therapy on surgery-free survival in CD

The introduction of biologics as a therapeutic option for Crohn’s disease had “only a slight impact” on eventual surgery occurrence, although it may delay the first intestinal resection compared with conventional therapy, data showed.
“Recently, conventional therapy has become increasingly unattractive due to its lower effectiveness in inducing and maintaining remission in the short-term period, compared to biological therapy,” Marco Valvano, MD, of the gastroenterology unit at University of L’Aquila, and colleagues wrote in BMC Gastroenterology. “Despite

Leave a Comment

Your email address will not be published. Required fields are marked *

Shopping Cart
This website uses cookies and asks your personal data to enhance your browsing experience.